CHU de Poitiers- Service d'Hépato-gastro-entérologie,

Poitiers 86021

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed